Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of icariside II in preparation of anti-melanoma medicament

A technology for icariside and melanoma, which is applied in the field of drug preparation and can solve the problems that the use of anti-melanoma drugs has not been reported yet.

Inactive Publication Date: 2011-05-25
AFFILIATED HUSN HOSPITAL OF FUDAN UNIV
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the use of icariside II in the preparation of anti-melanoma drugs has not yet been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of icariside II in preparation of anti-melanoma medicament
  • Application of icariside II in preparation of anti-melanoma medicament
  • Application of icariside II in preparation of anti-melanoma medicament

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Example 1 In vitro experiment of icariside II against melanoma cell lines

[0022] Materials and Methods

[0023] 1. Cell line: mouse melanoma cell line (B16), purchased from Shanghai Cell Bank, Chinese Academy of Sciences. Human melanoma cell lines (A375 and SK-MEL-2) were purchased from ATCC. The above cell lines were incubated in DMEM medium containing 10% fetal bovine serum at 37°C with a volume fraction of 5% CO 2 , Routine culture under fully saturated humidity conditions, replace the medium for 48 hours, when the cell growth reaches saturation, digest with 0.25% trypsin + 0.02% EDTA for passage, once every 2-3 days, the experiment uses logarithmic growth phase cells.

[0024] 2. Detection of cell proliferation:

[0025] Adjust the cell suspension concentration of B16, A375 and SK-MEL-2 cell lines to 1×10 5 / mL, added to 96-well culture plate, 100 μL per well, placed at 37°C 5% CO 2 Incubator for 24h. The old medium was sucked off, and serum-free DMEM medium...

Embodiment 2

[0037] Example 2: In vivo experiment of icariside II against melanoma

[0038] Materials and Methods

[0039] 1. Experimental animals: C57BL / 6J mice, male, 8 weeks old, raised in separate cages, 4 mice per cage. Two B16 tumor-bearing mice were male. The room temperature of the breeding environment is 20°C-25°C, the relative humidity is 50%-70%, and the light-dark cycle is 12h.

[0040] 2. Model preparation and group administration:

[0041] Two B16 tumor-bearing mice were sacrificed by cervical dislocation, and the tumor tissues were collected under aseptic conditions, chopped, ground, and sieved to prepare a tumor single-cell suspension, and the cell concentration was adjusted to 1×10 6 / ml. C57BL / 6J mice were subcutaneously inoculated with tumor single cell suspension in the right armpit, each 0.2mL (containing about 2×10 5tumor cells). On the 8th day of modeling, the C57BL / 6J mice were divided into 3 groups: tumor-bearing control group, medium-dose icariside II group,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicament preparation, relates to new medicinal application of icariside II, and particularly relates to application of icariside II in preparation of an anti-melanoma medicament. The icariside II is adopted for intervention experiments of mouse melanoma cell strains and human melanoma cell strains; by observing the inhibiting condition of the icariside II on cell proliferation, the results show that the icariside II can remarkably inhibit the proliferation of B16, A375 and SK-MEL-2 cells in vitro, obviously promote apoptosis of the cells and increase P53 protein phosphorylation and caspace protein expression; and the icariside II can remarkably inhibit loaded B16 mouse subcutaneous transplant tumor volume. Experiment results prove that the icariside II can effectively inhibit the melanoma. The icariside II can further be used for preparing the anti-melanoma medicament by adding proper pharmaceutically-acceptable carriers.

Description

Technical field: [0001] The invention belongs to the field of medicine preparation. The invention relates to a new medical application of icariside II, in particular to the application of icariside II in the preparation of anti-melanoma drugs. Background technique: [0002] Melanoma is a common clinical tumor, often primary in the skin and mucous membranes. Observations in clinical practice show that the degree of malignancy is high and distant metastasis is prone to occur. It is not sensitive to radiotherapy and chemotherapy, and its 5-year survival rate is very low. [0003] Screening active ingredients from natural medicines is a new direction for melanoma therapy. [0004] Icariside II is present in a small amount in Epimedium Herba, and its chemical structure is as follows: [0005] [0006] Icariside II [0007] At present, there are few reports on the pharmacological activity of epimedium. Chinese patent CN200780034447.9 discloses "Application of Icariside II...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61P35/00
Inventor 董竞成吴金峰刘宝君徐长青孙婧
Owner AFFILIATED HUSN HOSPITAL OF FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com